Status:
COMPLETED
Safety on Switching Between Different Botulinum Toxin-A
Lead Sponsor:
Nigar Dursun
Conditions:
Cerebral Palsy
Eligibility:
All Genders
2-18 years
Brief Summary
Clinical guidelines recommend the use of Botulinum Toxin-A (BoNT-A) for localized/segmental spasticity in children with cerebral palsy. At the Kocaeli University (KOU) Department of Physical Medicine ...
Detailed Description
A data base was designed to capture all data that were considered relevant to the treatment evaluation. The data were transcribed directly from participants medical records. For the purpose of the stu...
Eligibility Criteria
Inclusion
- children diagnosis of cerebral palsy with respect to Rosenbaum criteria,
- children having received repeated injections with two different types of toxinA treatment into their lower limb(s)
Exclusion
- children without repeated Botulinum toxin type A injections
- children having received repeated injections with same type of toxinA
Key Trial Info
Start Date :
July 30 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2017
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT03234413
Start Date
July 30 2017
End Date
November 30 2017
Last Update
January 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kocaeli University
Kocaeli, Turkey (Türkiye)